Cargando…
A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma
To precisely predict the clinical outcome and determine the optimal treatment options for patients with esophageal squamous cell carcinoma (ESCC) remains challenging. Prognostic models based on multiple molecular markers of tumors have been shown to have superiority over the use of single biomarkers...
Autores principales: | Zeng, Fa-Min, He, Jian-Zhong, Wang, Shao-Hong, Liu, De-kai, Xu, Xiu-E., Wu, Jian-Yi, Li, En-Min, Xu, Li-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899311/ https://www.ncbi.nlm.nih.gov/pubmed/31886273 http://dx.doi.org/10.1155/2019/9828637 |
Ejemplares similares
-
A three-gene signature and clinical outcome in esophageal squamous cell carcinoma
por: Sun, Ling-Ling, et al.
Publicado: (2015) -
A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis
por: Cao, Hui-Hui, et al.
Publicado: (2014) -
Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin‐bundling activity and tumor metastasis in esophageal squamous cell carcinoma
por: Zeng, Fa‐Min, et al.
Publicado: (2022) -
Desmocollin-2 affects the adhesive strength and cytoskeletal arrangement in esophageal squamous cell carcinoma cells
por: FANG, WANG-KAI, et al.
Publicado: (2014) -
A three-protein signature and clinical outcome in esophageal squamous cell carcinoma
por: Cao, Hui-Hui, et al.
Publicado: (2014)